ArticleThe Journal of antimicrobial chemotherapy2020

In vivo pharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria.

Kamilia Abdelraouf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.